CAS 184972-09-6

Exemestane Related Compound B (6-hydroxymethylandrostra-1,4-diene-3,17-dione)

CAS : 184972-09-6

Cyclanic, cyclenic or cycloterpenic ketones without oth

Formule : C₂₀H₂₆O₃

Couleur et forme : White Powder

Masse moléculaire : 314.18819

Ref: 45-1269072

Exemestane EP Impurity B (Exemestane USP Related Compound B) (Mixture of Diastereomers)

CAS : 184972-09-6

Formule : C₂₀H₂₆O₃

Couleur et forme : White To Off-White Solid

Masse moléculaire : 314.43

Ref: 4Z-E-1910

Exemestane

Produit contrôlé

CAS : 184972-09-6

Exemestane is an aromatase inhibitor that inhibits the production of estrogen in postmenopausal women. It is used to treat breast cancer and advanced prostate cancer. Exemestane binds to the hetrochromic region of the aromatase enzyme, blocking its access to the substrate, which is necessary for conversion of testosterone to estradiol. Inhibition of aromatase leads to decreased levels of estrogens and a decrease in estrogen-dependent symptoms such as hot flashes and night sweats. Exemestane also has been shown to have a beneficial effect on bone mineral density in postmenopausal women with osteoporosis. Exemestane has been approved by the FDA for use in breast cancer treatment and advanced prostate cancer treatment since 1998.

Formule : C₂₀H₂₆O₃

Degré de pureté : Min. 95%

Masse moléculaire : 314.4 g/mol

Ref: 3D-JHA97209

Exemestane EP Impurity B

CAS : 184972-09-6

Formule : C₂₀H₂₆O₃

Masse moléculaire : 314.4

Ref: ST-EA-CP-E45002